GlassScriptPhysician profile
Lynn Wolff
NPI 1013231398
$3,339.67
in general payments reported to CMS, 2019-2025
27 companies · $2,243 in 2025
The $2,243 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.51 · 2024: $1,078 · 2025: $2,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,863 · Education: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,863.21 |
| Education | $456.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $807.08 | 2024-2025 | Fasenra, Airsupra, Tezspire |
| Actelion Pharmaceuticals US, INC. | $395.08 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $340.66 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $260.25 | 2024-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $237.60 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $206.50 | 2024-2025 | Aralast |
| Viatris Specialty LLC | $168.57 | 2025 | Yupelri |
| Mylan Specialty L.P. | $120.74 | 2024 | Yupelri |
| Electromed, INC. | $103.59 | 2025 | Smartvest |
| Verona Pharma, INC. | $91.01 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $83.58 | 2024-2025 | Sunosi |
| Grifols USA, LLC | $81.68 | 2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $57.89 | 2024-2025 | Tyvaso, Tyvaso |
| Ani Pharmaceuticals, INC. | $56.20 | 2025 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $40.91 | 2025 | Inspire |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $37.91 | 2024 | Entre Plus, Flexitouch Plus |
| Baxter Healthcare | $34.58 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $32.34 | 2025 | Vest Therapy Und |
| Pulmonx Corporation | $25.05 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Lilly USA, LLC | $22.68 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $21.99 | 2024 | Lumryz |
| Insmed, INC. | $21.87 | 2025 | Arikayce |
| Inogen, INC. | $21.16 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.00 | 2025 | Ofev |
| Chiesi USA, INC. | $19.51 | 2021 | |
| Breas Medical, INC. | $15.54 | 2024 | Vivo 45 Ls |
| Jazz Pharmaceuticals INC. | $14.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.